8th Annual Tumour Models, San Francisco, CA, Jan 30-Feb 01, 2024

Conference

genOway presentation

Event
-
January 23, 2024

Jan 30-Feb 01, 2024

Implementing State-of-the-Art, Reproducible Preclinical Oncology Models to Accelerate Your Candidate’s Clinical Translatability

8th Tumour Models San Francisco

genOway’s presentation:

How to enhance translatability of immunotherapies in preclinical models

  • Outlining BRGSF-HIS mice: Immunodeficient mice displaying functional human lymphoid and myeloid compartments, without GvHD and side effects
  • Examining human cells functionality and assessing immune modulation induced by biologics in BRGSF-HIS model
  • Showcase of assessment of immune targeting agents in immune checkpoint humanized models

Other news & events

genOway signs a three-year contract with a global philanthropic organization supporting the development of infectious diseases therapies
Partnership
News
-
Feb 2025
Read on
9th Tumor Models San Francisco Summit 2025, January 29-30, 2025
Conference
genOway presentation
Event
-
Jan 2025
Read on
13th Tumour Models London Summit 2024, December 4-5, 2024
Conference
genOway presentation
Event
-
Dec 2024
Read on
39th SITC meeting 2024, Houston, TX, November 6-10
Conference
genOway presentation
Event
-
Oct 2024
Read on
ESMO (European Society For Medical Oncology) 2024, Barcelona, Spain, September 13-17, 2024
Conference
genOway presentation
Event
-
Sep 2024
Read on